A. Widmer

2.6k citations
14 papers · 1.3k indexed · 1 hit paper · h-index 8

A. Widmer

14 papers receiving 1.3k citations

Hit Papers

Use of Canakinumab in the Cryopyrin-Associated Periodic S...6272009202620142020200400600

Peers

A. Widmer
Comparison fields: 5 of 80
  • Hematology 467
  • Immunology 663
  • Rheumatology 387
  • Nephrology 141
  • Dermatology 122
Replace Ayşe Çefle with:
Ayşe Çefle Türkiye
İzzet Fresko Türkiye
R. H. W. M. Derksen Netherlands
A. Accardo-Palumbo Italy
F. C. Breedveld Netherlands
Szilvia Szamosi Hungary
Élisabeth Palazzo France
Chanyuan Wu China
Alexandros Garyfallos Greece
Hans‐Jacob Haga Norway
A. Widmer relative to Ayşe Çefle Türkiye Ayşe Çefle's profile →
Citations per field
00.5×3.4×
Ayşe Çefle · 1×
Citations per year

Countries citing papers authored by A. Widmer

Since Specialization
Citations

This map shows the geographic impact of A. Widmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Widmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Widmer more than expected).

Fields of papers citing papers by A. Widmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Widmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Widmer. The network helps show where A. Widmer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Widmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Widmer Line = papers co-authored together A. Widmer links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201961
2 20191
3 2019215
4 20183
5
Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis and Psoriasis: Results From a Pooled Safety Analysis
20162
6 201632
7 20156
8 2011114
9 2011154
10
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndromebreakdown →
2009627
11 200378
12
[Influence of diagnosis, hospital and sex on the effects of bromperidol].
19791
13 197723
14 19751

About A. Widmer

A. Widmer is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Orthopedics and Sports Medicine, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Spondyloarthritis Studies and Treatments (5 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Chronic Lymphocytic Leukemia Research (2 papers), Inflammasome and immune disorders (2 papers), Lightning and Electromagnetic Phenomena (1 paper) and Electrical Fault Detection and Protection (1 paper). The work is most often cited by research in Hematology (467 citations), Immunology (663 citations), Rheumatology (387 citations), Nephrology (141 citations) and Dermatology (122 citations). A. Widmer has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Xavier Gitton, É. Hachulla, Kieron Leslie, Helen J. Lachmann, Philip N. Hawkins, Pierre Quartier, Jasmin Kuemmerle‐Deschner, Isabelle Koné‐Paut, Luminita Pricop and Brian Porter. Their work appears in journals such as Annals of the Rheumatic Diseases, Obstetrical & Gynecological Survey, Lara D. Veeken, New England Journal of Medicine and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026